In 2024, LifeArc announced a 10 million funding call for projects repurposing existing treatments for bronchiectasis. Several registries have also been formed (eg, the European Bronchiectasis Registry and the Bronchiectasis and NTM Research Registry) to improve understanding of non-cystic fibrosis bronchiectasis.
by J Wang 2024 Cited by 2Furthermore, nanoparticle-based drug delivery systems can protect the drugs Bronchiectasis, and the Chronic Obstructive Pulmonary Disease–Bronchiectasis
Asthma and bronchiectasis are often partners in a complex relationship.13 Future pragmatic RCTs evaluating biological drugs in bronchiectasis patients with a T2
Medications for Bronchiectasis Correct Use of Medications Order of Medications Medications for Bronchiectasis When well, many patients do not require specific medications for bronchiectasis and may be maintained with an exercise and airway clearance regimen. The following medications may be indicated: Antibiotics Antibiotics are central to the management of bronchiectasis. The selection of the
Bronchiectasis affects 350,000 to 500,000 adults in the United States. The risk of developing bronchiectasis increases with age. Bronchiectasis is more common in women than in men. There are many causes of bronchiectasis, but for about 40% of cases the cause is unknown. This is called idiopathic bronchiectasis.
by K Li 2024 Cited by 1Azithromycin is effective to prevent exacerbation of non-cystic fibrosis bronchiectasis. Peer Review reports. Introduction. Bronchiectasis is
Respiratory Tract Disease; Bronchiectasis. Medications for Bronchiectasis. Bronchiectasis is destruction and widening of the large airways. If the condition is
Medications for Bronchiectasis Correct Use of Medications Order of Medications Medications for Bronchiectasis When well, many patients do not require specific medications for bronchiectasis and may be maintained with an exercise and airway clearance regimen. The following medications may be indicated: Antibiotics Antibiotics are central to the management of bronchiectasis. The selection of the
The current management of bronchiectasis is based on targeting the underlying pathophysiology of bronchiectasis. There are no licensed drug
Comments
LWlurker